Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability, Pharmacokinetics and Pharmacodynamics of Insulin Aspart Administered in the Duodenum in Healthy Volunteers
2006-002803-15Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of insulin aspart in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Aarhus University Hospital. Primary endpoints: Pharmacokinetics of insulin aspart and Bioavailability of insulin aspart. Started Jun 2006; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002803-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002803-15.